Long COVID Syndrome
16
8
10
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (16)
Micro-choice-based Intervention for Multicausal Fatigue
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Dapagliflozin for Long COVID Syndrome
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID
A Study to Examine Anktiva for the Treatment of COVID-19.
A Fasting Pilot Study for Long COVID
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Immunoadsorption in Autoimmune Long COVID
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Characteristics of Long COVID-19 Syndrome
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19
Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID